Literature DB >> 23205952

A prospective population-based cohort study of the prevalence, incidence and impact of obsessive-compulsive symptomatology.

Naomi A Fineberg1, Michael P Hengartner, Carmel E Bergbaum, Tim M Gale, Alex Gamma, Vladeta Ajdacic-Gross, Wulf Rössler, Jules Angst.   

Abstract

OBJECTIVE: Prospective longitudinal studies of obsessive-compulsive disorder (OCD) and sub-diagnostic obsessive-compulsive symptomatology in the non-clinical population, using age-defined cohorts, are rare. This study aimed to investigate the effect of OC symptoms on distress and psychosocial function and the effect of early-onset OC symptoms.
METHODS: 591 subjects drawn from the general population of Zurich, Switzerland were interviewed seven times between 1979 (at age 20/21) and 2008 (age 49/50). Data for socio-demographic variables and psychosocial impairment was also collected and compared with a control-group without OC symptoms drawn from the same population.
RESULTS: The unweighted cumulative one-year rate of OCD in this sample was 5.1% and 21.7% reported some degree of clinically-relevant OC symptomatology (OCD or OCS). OCD appeared more prevalent in females whereas OCS and OC symptoms were more prevalent in males. The weighted cumulative prevalence rates, representative of the general population, for OCD, OCS and OC symptoms were 3.5%, 9.7%, and 11.2%, respectively. We could not identify OCD occurring before the age of 10 years, though sub-threshold cases were reported as early as age 2 years, whereas by the age of 22 years, around two thirds of OCD cases had emerged and no new cases developed OCD after around 37 years. Males were statistically significantly younger than females at onset of any OC symptomatology.
CONCLUSIONS: Clinically-relevant OC syndromes start early and are associated with substantial distress, treatment-seeking activity and in the case of OCD, functional disability.

Entities:  

Mesh:

Year:  2013        PMID: 23205952     DOI: 10.3109/13651501.2012.755206

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  15 in total

1.  On the Development of OCD.

Authors:  T U Hauser
Journal:  Curr Top Behav Neurosci       Date:  2021

2.  Comparing two basic subtypes in OCD across three large community samples: a pure compulsive versus a mixed obsessive-compulsive subtype.

Authors:  Stephanie Rodgers; Vladeta Ajdacic-Gross; Wolfram Kawohl; Mario Müller; Wulf Rössler; Michael P Hengartner; Enrique Castelao; Caroline Vandeleur; Jules Angst; Martin Preisig
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-04-01       Impact factor: 5.270

3.  Executive Functions and Reinforcement Sensitivity in Women with Obsessive Compulsive Symptoms.

Authors:  Malahat Amani; Safoora Keyvanlo
Journal:  Iran J Psychiatry       Date:  2022-04

4.  Demographic and health-related correlates of obsessive-compulsive symptoms among African Americans.

Authors:  Monnica T Williams; Robert Joseph Taylor; Joseph A Himle; Linda M Chatters
Journal:  J Obsessive Compuls Relat Disord       Date:  2017-07-08       Impact factor: 1.677

5.  Age-Specific Prevalence of Hoarding and Obsessive Compulsive Disorder: A Population-Based Study.

Authors:  Danielle C Cath; Krystal Nizar; Dorret Boomsma; Carol A Mathews
Journal:  Am J Geriatr Psychiatry       Date:  2016-11-10       Impact factor: 4.105

6.  Cognitive-behavioural therapy for obsessive-compulsive disorder co-occurring with psychosis: Systematic review of evidence.

Authors:  Antonio Tundo; Roberta Necci
Journal:  World J Psychiatry       Date:  2016-12-22

Review 7.  Mapping Compulsivity in the DSM-5 Obsessive Compulsive and Related Disorders: Cognitive Domains, Neural Circuitry, and Treatment.

Authors:  Naomi A Fineberg; Annemieke M Apergis-Schoute; Matilde M Vaghi; Paula Banca; Claire M Gillan; Valerie Voon; Samuel R Chamberlain; Eduardo Cinosi; Jemma Reid; Sonia Shahper; Edward T Bullmore; Barbara J Sahakian; Trevor W Robbins
Journal:  Int J Neuropsychopharmacol       Date:  2018-01-01       Impact factor: 5.176

Review 8.  Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder.

Authors:  Zoya Marinova; De-Maw Chuang; Naomi Fineberg
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

9.  Treatment of Hypochondriasis in Two Schizophrenia Patients Using Clozapine.

Authors:  Antonio Tundo; Luca Proietti; Rocco de Filippis
Journal:  Case Rep Psychiatry       Date:  2017-05-31

10.  Predictors of trajectories of obsessive-compulsive symptoms during the COVID-19 pandemic in the general population in Germany.

Authors:  Lena Jelinek; Anja S Göritz; Franziska Miegel; Steffen Moritz; Levente Kriston
Journal:  Transl Psychiatry       Date:  2021-05-27       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.